Skip to main content
All lobbying clients

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Lobbying client · District of Columbia · filed 2025 to 2026

Representing manufacturers/distributors of OTC drugs/dietary supplements/medical devices.

$2,382,824 Reported spend
34 Filings counted
4 Outside firms hired
23 Bills named

Spend is reported income plus in-house expenses across 34 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 5 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

 Who filed for this client 5

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 23
  • H.R. 1219
    Oral Health Products Inclusion Act
    7 filings
  • H.R. 1
    One Big Beautiful Bill Act
    6 filings
  • H.R. 2821
    FDA Modernization Act 3.0
    6 filings
  • H.R. 3686
    SAFE Sunscreen Standards Act
    6 filings
  • H.R. 4273
    Over-the-Counter Monograph Drug User Fee Amendments
    6 filings
  • S. 355
    FDA Modernization Act 3.0
    6 filings
  • H.R. 4958
    GRAS Act
    5 filings
  • H.R. 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and E…
    5 filings
  • S. 2292
    Over-the-Counter Monograph Drug User Fee Amendments
    5 filings
  • S. 2491
    SAFE Sunscreen Standards Act
    5 filings
  • S. 2529
    A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonpre…
    5 filings
  • H.R. 6868
    ACCESS Through OTC Innovation Act
    4 filings
  • S. 3122
    Better FDA Act of 2025
    4 filings
  • H.R. 7366
    Dietary Supplement Regulatory Uniformity Act
    3 filings
  • H.R. 3722
    21st Century Infrastructure Bank Act
    2 filings
  • H.R. 5027
    Ban Harmful Food Dyes Act
    2 filings
  • H.R. 7291
    GRAS Oversight and Transparency Act
    2 filings
  • H.R. 8370
    Dietary Supplement Listing Act of 2026
    2 filings
  • H.R. 8385
    Food Labeling Modernization Act of 2026
    2 filings
  • H.R. 8933
    Dietary Supplements Access Act
    2 filings
  • S. 3788
    CLEAR LABELS Act
    2 filings
  • S. 4587
    Dietary Supplements Access Act
    2 filings
  • H.R. 10336
    Dietary Supplement Innovation Act
    1 filing
 Reported by year 2 years
  • 2026 $895,566 13 filings
  • 2025 $1,487,258 21 filings
 Issues lobbied 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 8
  • HOUSE OF REPRESENTATIVES 21
  • SENATE 21
  • Food & Drug Administration (FDA) 8
  • White House Office 8
  • Drug Enforcement Administration (DEA) 7
  • Health & Human Services, Dept of (HHS) 7
  • Centers For Medicare and Medicaid Services (CMS) 2
  • Commerce, Dept of (DOC) 1
 Recent filings 34 total
Q3 report
ALSTON & BIRD LLP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $70,000 income · posted Oct 20, 2026
View →
Q3 reportNo activity
COVINGTON & BURLING LLP
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 19, 2026
View →
Q3 report
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $146,407 income · posted Oct 13, 2026
View →
Q3 report
KOUNTOUPES DENHAM CARR & REID, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 8, 2026
View →
Q2 report
ALSTON & BIRD LLP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $70,000 income · posted Jul 20, 2026
View →
Q2 reportNo activity
COVINGTON & BURLING LLP
2nd Quarter 2026 (Apr 1 - June 30) · posted Jul 17, 2026
View →
Q2 report
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $199,750 income · posted Jul 14, 2026
View →
Q2 report
KOUNTOUPES DENHAM CARR & REID, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 8, 2026
View →
Q1 report
ALSTON & BIRD LLP
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $70,000 income · posted Apr 20, 2026
View →
Q1 reportNo activity
COVINGTON & BURLING LLP
1st Quarter 2026 (Jan 1 - Mar 31) · posted Apr 17, 2026
View →
Q1 terminationNo activity
SQUIRE PATTON BOGGS
1st Quarter 2026 (Jan 1 - Mar 31) · posted Apr 14, 2026
View →
Q1 report
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $159,409 income · posted Apr 14, 2026
View →
Q1 report
KOUNTOUPES DENHAM CARR & REID, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 9, 2026
View →
Q4 report
ALSTON & BIRD LLP
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 20, 2026
View →
Q4 reportNo activity
COVINGTON & BURLING LLP
4th Quarter 2025 (Oct 1 - Dec 31) · posted Jan 16, 2026
View →
Q4 reportNo activity
SQUIRE PATTON BOGGS
4th Quarter 2025 (Oct 1 - Dec 31) · posted Jan 15, 2026
View →
Q4 report
KOUNTOUPES DENHAM CARR & REID, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 14, 2026
View →
Q4 report
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $245,484 income · posted Jan 14, 2026
View →
Q3 reportNo activity
COVINGTON & BURLING LLP
3rd Quarter 2025 (July 1 - Sep 30) · $20,000 income · posted Oct 20, 2025
View →
Q3 report
ALSTON & BIRD LLP
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2025
View →

Showing the 20 most recent of 34 filings. Search the explorer for "CONSUMER HEALTHCARE PRODUCTS ASSOCIATION".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem